Labeled Ouabain. A cardiac glycoside that inhibits Na(+)/K(+) ATPase. It regulates transcription of MDR (increase, Pgp) and MRP (increase MRP1 and decrease CFTR, cyctic fibrosis transport receptor or cAMP-activated Cl- channel) genes, also alters localization of MRP1. Melting Point: As Reported Solubility: As Reported Method for Determining Identity: Proton NMR (CD3OD) Spectroscopic and Mass Spectrometric analysis TLC Conditions: As Reported Elemental Analysis: As Reported Normalized Intensity: As Reported Storage and Stability: May be stored at RT for short-term only. Long-term storage is recommended at 4C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Store under inert atmosphere. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. Toxicity and Hazards: All products should be handled by qualified personnel only, trained in laboratory procedures.
Molecular Weight:
587.67
Purity:
~90%
* VAT and and shipping costs not included. Errors and price changes excepted
